Injective (INJ) is currently trading at $3.36, reflecting a 2.48% increase over the past 24 hours. The daily range has been relatively tight, with a high of $3.40 and a low of $3.25, indicating stable price action in the short term.

Volume stands at 46,017,750, translating to a volume-to-market cap ratio of 13.66%, which is healthy and suggests active trading interest. The hourly moving averages indicate bullish momentum, with the 8 SMA at $3.34 showing a 0.51% increase, while longer-term SMAs also reflect upward trends, particularly the 144 SMA at $3.29 with a 2.26% rise.

The 1-hour RSI at 67 indicates that INJ is nearing overbought conditions, which could lead to a temporary pullback. However, the 7-day RSI at 50 suggests a neutral position, meaning there is potential for further upward movement without immediate selling pressure.

Despite a slight decline of 1.48% over the past week, the cryptocurrency has performed well over the last 14 days, gaining approximately 13.56%. The 30-day performance is also positive at 9.54%, suggesting a longer-term upward trend.

Considering the current price action, volume, and moving averages, the outlook for INJ remains cautiously optimistic. However, the high RSI on the hourly chart warrants vigilance for potential corrections.

Given the current technical indicators and recent price performance, a Buy rating is appropriate, as there is still room for growth, especially with the support from longer-term moving averages. The potential for upward movement aligns well with the overall market sentiment and trading volume.